The association of diabetes mellitus with the severity of angiographic findings in patients with newly-diagnosed coronary artery disease
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2011, Vol 28, Issue 2
Abstract
OBJECTIVE The purpose of this study was to compare the severity of angiographic findings in patients with newlydiagnosed coronary artery disease (CAD) with and without diabetes mellitus (DM). METHOD A retrospective study was performed on 115 inpatients with new-onset CAD presenting with either acute myocardial infarction (n=84) or unstable angina (n=31) between 2005 and 2007, who underwent coronary angiography during hospitalization. A history of previous cardiovascular disease (stroke, peripheral arterial disease, atrial fibrillation) was sought in the study participants and medical treatment prior to hospitalization was recorded. Measurement of serum myocardial enzymes and lipids was performed in all patients. The Gensini score was calculated to assess CAD severity, taking into account the number and degree of vascular stenotic lesions and their anatomical location. Statistical analysis was performed using Chi-square and Student's T-test. RESULTS The incidence of DM in the study population was 20.9% (n=24). For the patients with DM, antidiabetic treatment before hospital admission included monotherapy or combination therapy in 20.8% (n=5) and 62.6% (n=15), respectively and 16.7% (n=4) had not taken oral hypoglycemic agents or insulin prior to hospitalization. The incidence of stroke and atrial fibrillation was significantly higher in the patients with DM than in the non-diabetic patients with new-onset CAD (x2=7.353, p=0.028 and x2=8.040, p=0.017, respectively). In addition, the patients with DM had significantly higher Gensini scores (42.09±8.39 vs 35.4±3.069 [95% CI], p=0.036). CONCLUSIONS Among the patients with new-onset CAD, the presence of DM was associated with higher cardiovascular morbidity and significantly greater severity of the coronary angiography findings. DM was correlated with multifocal distribution of atherosclerotic lesions and a greater degree of coronary artery luminal stenosis.
Authors and Affiliations
V. PEPPES, A. PANOUTSOPOULOS, G. RAMMOS, N. ZAKOPOULOS
Keywords
Related Articles
- EP ID EP144986
- DOI -
- Views 81
- Downloads 0
100 terms glossary of epidemiology (in Greek) <br /> <br />
OBJECTIVE The purpose of this study was to record the 100 epidemiological terms most frequently used in medical research. METHOD Epidemiology and biostatistics textbooks used by all the medical schools in Greece were re...
Skin diseases and inflammatory bowel disease. Part II. Nosological parallels, diagnostic problems and adverse effects of treatment: Fields for collaboration between gastroenterologists and dermatologists
In nosological terms, there is a striking pathophysiological resemblance between certain subgroups of skin and gastrointestinal diseases, probably as a result of the overall structural similarity of the two systems. Desp...
Oxidative stress: Study techniques and its effects on gonadal function
This is a review of the mechanisms that contribute to the development of oxidative stress and its effects. The substances involved in oxidative stress and their effects on major biomolecules are described, and the ways i...
Computerized tomography and magnetic resonance imaging scanners public hospital coverage:<br /> A comparative analysis between Greece and England
OBJECTIVE Το evaluate the regional distribution of computerized tomography (CT) and magnetic resonance imaging (MRI) scanners and their coverage in public hospitals of the national health services of Greece (ESY) and Eng...
Recombinant polypeptides of the acetylcholine receptor in the development<br /> of an antigen-specific therapy for myasthenia gravis through the immunoadsorption <br /> of anti-receptor antibodies from myasthenic patients
OBJECTIVE The pathology of the autoimmune disease myasthenia gravis is largely explained by autoantibodies produced against the human muscle acetylcholine receptor. Plasmapheresis offers a significant therapeutic option...